Arijita Deb1, Usha Sambamoorthi1, James Douglas Thornton1, Bernard Schreurs2, Kim Innes3. 1. a Department of Pharmaceutical Systems and Policy, School of Pharmacy , West Virginia University , Morgantown , WV , United States. 2. b Department of Physiology and Pharmacology , School of Medicine, West Virginia University , Morgantown , WV , United States. 3. c Department of Epidemiology , School of Public Health, West Virginia University , Morgantown , WV , United States.
Abstract
OBJECTIVE: To estimate the excess direct annual healthcare expenditures associated with Alzheimer's and related dementias(ADRD) among community-dwelling older adults in the United States. METHODS: This retrospective cross-sectional study compared the annual healthcare expenditures between elderly individuals aged 65 years and older with ADRD (n = 662) and without ADRD (n = 13,398) using data from the Medical Expenditure Panel Survey (MEPS) for the years 2007, 2009, 2011 and 2013. Adjusted total annual medical expenditures was estimated using generalized linear model with gamma distribution and log link in 2013 U.S. dollars. Adjusted inpatient, outpatient, emergency, home healthcare and prescription drug expenditures, were estimated using two-part logit-generalized linear regression models. RESULTS: The adjusted mean total healthcare expenditures were higher for the ADRD group as compared to the no ADRD group($14,508 vs. $10,096). Among those with ADRD, 34.3% of the expenditures were for home healthcare as compared to 4.4% among those without ADRD. Among users, the ADRD group had significantly higher home healthcare ($3,240 vs. $566) and prescription drug expenditures($3,471 vs. $2,471). There were no statistically significant differences in inpatient, emergency room and outpatient expenditures between the ADRD and no ADRD group. CONCLUSION: ADRD in U.S. community-dwelling elders is associated with significant financial burden, primarily driven by increased home healthcare use.
OBJECTIVE: To estimate the excess direct annual healthcare expenditures associated with Alzheimer's and related dementias(ADRD) among community-dwelling older adults in the United States. METHODS: This retrospective cross-sectional study compared the annual healthcare expenditures between elderly individuals aged 65 years and older with ADRD (n = 662) and without ADRD (n = 13,398) using data from the Medical Expenditure Panel Survey (MEPS) for the years 2007, 2009, 2011 and 2013. Adjusted total annual medical expenditures was estimated using generalized linear model with gamma distribution and log link in 2013 U.S. dollars. Adjusted inpatient, outpatient, emergency, home healthcare and prescription drug expenditures, were estimated using two-part logit-generalized linear regression models. RESULTS: The adjusted mean total healthcare expenditures were higher for the ADRD group as compared to the no ADRD group($14,508 vs. $10,096). Among those with ADRD, 34.3% of the expenditures were for home healthcare as compared to 4.4% among those without ADRD. Among users, the ADRD group had significantly higher home healthcare ($3,240 vs. $566) and prescription drug expenditures($3,471 vs. $2,471). There were no statistically significant differences in inpatient, emergency room and outpatient expenditures between the ADRD and no ADRD group. CONCLUSION:ADRD in U.S. community-dwelling elders is associated with significant financial burden, primarily driven by increased home healthcare use.
Entities:
Keywords:
Alzheimer's; Medical Expenditure Panel Survey; dementia; direct medical expenditures
Authors: Dario Gregori; Michele Petrinco; Simona Bo; Alessandro Desideri; Franco Merletti; Eva Pagano Journal: Int J Qual Health Care Date: 2011-04-19 Impact factor: 2.038
Authors: Michael D Hurd; Paco Martorell; Adeline Delavande; Kathleen J Mullen; Kenneth M Langa Journal: N Engl J Med Date: 2013-04-04 Impact factor: 91.245
Authors: William James Deardorff; Phillip L Liu; Richard Sloane; Courtney Van Houtven; Carl F Pieper; Susan Nicole Hastings; Harvey J Cohen; Heather E Whitson Journal: J Am Geriatr Soc Date: 2019-03-29 Impact factor: 5.562
Authors: Krista R Schaefer; Carolyn Noonan; Michael Mosley; Julia Smith; Donna Galbreath; David Fenn; Renee F Robinson; Spero M Manson Journal: Alzheimers Dement Date: 2019-09-25 Impact factor: 21.566
Authors: Douglas Thornton; Nilanjana Dwibedi; Virginia Scott; Charles D Ponte; X I Tan; Douglas Ziedonis; Usha Sambamoorthi Journal: Am J Accountable Care Date: 2018-12-05
Authors: Julia Burgdorf; John Mulcahy; Halima Amjad; Judith D Kasper; Kenneth Covinsky; Jennifer L Wolff Journal: J Prim Care Community Health Date: 2019 Jan-Dec
Authors: Sayeh Bayat; Ganesh M Babulal; Suzanne E Schindler; Anne M Fagan; John C Morris; Alex Mihailidis; Catherine M Roe Journal: Alzheimers Res Ther Date: 2021-06-14 Impact factor: 6.982